2025
SJR Q2
JCR Q1 · 4,7
28 matched articles
SCIE
Journal detail
Journal of Liposome Research
- Publisher
- Taylor and Francis Ltd.
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
0898210415322394
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,702
- Quartile Q2
- H-Index 72
- Cites/doc 5,81
- Docs (3y) 112
- Cites (3y) 633
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 4,7
- 5Y JIF 5,2
- JCI 0,82
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Pharmaceutical Science Q2
Areas
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Biochemistry & Molecular Biology | Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q1 | 0,702 | 4,7 | 5,2 | 0,82 | Q2 | 72 |
| 2024 | Q2 | Q1 | 0,619 | 4,3 | 5 | 0,77 | Q2 | 70 |
| 2023 | Q1 | Q2 | 0,747 | 3,6 | 4,8 | 0,78 | Q2 | 70 |
| 2022 | Q1 | Q2 | 0,75 | 4,4 | 4,1 | 0,93 | Q2 | 70 |
| 2021 | Q2 | Q1 | 0,676 | 5,6 | 4,5 | 0,91 | Q2 | 70 |
| 2020 | Q2 | Q2 | 0,579 | 3,6 | 3,6 | 0,82 | Q2 | 70 |
| 2019 | Q2 | Q3 | 0,451 | 2,5 | 2,4 | 0,66 | Q3 | 70 |
| 2018 | — | Q3 | — | 2,5 | 2,5 | 0,67 | Q3 | — |
| 2017 | Q2 | Q2 | 0,65 | 2,6 | 2,5 | 0,67 | Q3 | 70 |
| 2016 | Q2 | Q3 | 0,566 | 2 | 2 | — | — | 70 |
| 2015 | Q1 | Q3 | 0,576 | 1,8 | 1,9 | — | — | 70 |
| 2014 | Q1 | Q3 | 0,65 | 1,8 | 1,8 | — | — | 70 |
| 2013 | Q1 | Q3 | 0,608 | 1,5 | 1,9 | — | — | 70 |
| 2012 | Q1 | Q3 | 0,736 | 1,9 | 2 | — | — | 70 |
| 2011 | Q1 | Q3 | 0,64 | 1,7 | 2,2 | — | — | 70 |
| 2010 | Q1 | Q3 | 0,647 | 1,8 | 2,1 | — | — | 70 |
| 2009 | — | Q3 | — | 1,8 | 1,9 | — | — | — |
| 2008 | — | Q3 | — | 2,1 | 1,9 | — | — | — |
| 2007 | — | Q3 | — | 2 | 1,7 | — | — | — |
| 2006 | — | Q4 | — | 1 | — | — | — | — |
| 2005 | — | Q4 | — | 1 | — | — | — | — |
| 2004 | — | Q3 | — | 1,3 | — | — | — | — |
| 2003 | — | Q4 | — | 0,6 | — | — | — | — |
| 2002 | — | Q3 | — | 0,8 | — | — | — | — |
| 2001 | — | Q3 | — | 1,2 | — | — | — | — |
| 2000 | — | Q2 | — | 1,4 | — | — | — | — |
| 1999 | — | Q2 | — | 1,4 | — | — | — | — |
| 1998 | — | Q2 | — | 1,2 | — | — | — | — |
| 1997 | — | Q4 | — | 0,6 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q2 | 95/328 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q2 | 78/356 |
| 2024 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q2 | 91/320 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q2 | 69/352 |
| 2023 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q2 | 126/313 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 94/354 |
| 2022 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q2 | 103/285 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 81/278 |
| 2021 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q2 | 89/297 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q2 | 61/279 |
| 2020 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q2 | 166/295 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 128/276 |
| 2019 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 199/297 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 159/271 |
| 2018 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 176/299 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 137/267 |
| 2017 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 168/293 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 126/261 |
| 2016 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 216/290 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 165/257 |
| 2015 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 221/289 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 167/255 |
| 2014 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 221/290 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 162/255 |
| 2013 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 241/291 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 173/256 |
| 2012 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 216/290 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 159/261 |
| 2011 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 223/290 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 168/261 |
| 2010 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 204/286 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 152/252 |
| 2009 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 200/283 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 150/237 |
| 2008 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 170/275 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 124/219 |
| 2007 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 166/263 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 111/205 |
| 2006 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 218/262 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 154/199 |
| 2005 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 216/261 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 154/193 |
| 2004 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 198/261 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 122/187 |
| 2003 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 238/261 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 164/185 |
| 2002 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 222/266 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 141/188 |
| 2001 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 214/308 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 108/186 |
| 2000 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 192/310 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 82/181 |
| 1999 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 178/295 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 72/175 |
| 1998 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 185/295 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 85/178 |
| 1997 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 228/253 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 122/157 |